Selinexor, a Selective Inhibitor of Nuclear Export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma
Selinexor, a Selective Inhibitor of Nuclear Export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma